Relapsed Hodgkin Lymphoma
In some cases, Hodgkin lymphoma may return, even after patients have achieved a remission. The return of the disease is referred to as a "relapse." For these patients, Hodgkin lymphoma is still potentially curable. The doctor will treat these patients again with chemotherapy. The treatment often gives patients very long disease-free periods. Two treatment options for relapsed Hodgkin lymphoma are
- Brentuximab vedotin (Adcetris®)
- Nivolumab (Opdivo®)
For more information, visit Drug Listings.
Refractory Hodgkin Lymphoma
A small percentage of patients have disease that does not respond to initial treatment. This is called "refractory" Hodgkin lymphoma. These patients often require treatment consisting of high-dose chemotherapy followed by autologous stem cell transplantation.